ライフサイエンスコーパス: viral regulatory protein

1 functional analysis of this immediate-early viral regulatory protein.

2 ach for structural studies of this enigmatic viral regulatory protein.

3 induce apoptosis was attributable to Tat, a viral regulatory protein.

4 ed cell protein 0 (ICP0) promoter, a crucial viral regulatory protein.

5 recently been ascribed to some of the known viral regulatory proteins.

6 wide variety of proteins, including several viral regulatory proteins.

7 nfection prior to the participation of other viral regulatory proteins.

8 we review the current understanding of three viral regulatory proteins.

9 tein synthesis with de novo synthesis of the viral regulatory proteins.

10 The functions of these viral regulatory proteins are in part interchangeable; t

11 Many eukaryotic and viral regulatory proteins are known to undergo posttrans

12 Viral regulatory proteins are not abundantly expressed d

13 hout clinical symptoms of VZV infection that viral regulatory proteins are present in latently infect

14 encoded by bovine herpesvirus 1 is the major viral regulatory protein because it stimulates all viral

15 by infected cell protein 4 (ICP4), the major viral regulatory protein, binding to its cognate site at

16 ency of viral infection and the functions of viral regulatory proteins, but the underlying molecular

17 In summary, our study suggests that a viral regulatory protein can modulate the DNA binding ac

18 ific for IEP and EICP22P revealed that these viral regulatory proteins colocalize in the nucleus at e

19 reases the number of TG neurons that express viral regulatory proteins during early stages of explant

20 ntron-containing RNA is mediated by specific viral regulatory proteins (e.g., human immunodeficiency

21 examethasone induced expression of all three viral regulatory proteins following TG explant.

22 to evaluate a role for HBV infection and the viral regulatory protein HBx to drive HIF-signalling.

23 simplex virus type 1 (HSV-1) infection, the viral regulatory protein ICP0 localizes to ND10 and indu

24 pe 1 (HSV-1) infection in the absence of the viral regulatory protein ICP0.

25 es simplex virus type 1 (HSV-1) infection by viral regulatory protein ICP0.

26 nse bodies which did not colocalize with the viral regulatory protein ICP0.

27 re to produce normal levels of this critical viral regulatory protein in the presence of COX-2 inhibi

28 implex virus (HSV) genomes in the absence of viral regulatory proteins in sensory neurons is poorly u

29 y inhibiting specific steps or activities of viral regulatory proteins, indicating the broad and plei

30 exhibit defined structures which contain two viral regulatory proteins (infected cell proteins 4 and

31 nd functional interplay between YB-1 and the viral regulatory protein large T antigen (T-antigen), us

32 Nef is a viral regulatory protein of the human immunodeficiency v

33 fection and that the level of ICP27, a third viral regulatory protein, plays an important role in det

34 binding motif (Rep binding site [RBS]) for a viral regulatory protein (Rep) separated by a short DNA

35 nd p19 promoters direct the synthesis of the viral regulatory proteins, Rep78 and -68 and Rep52 and -

36 A viral regulatory protein, Rev, specifically induces the

37 mes, however, this defense is antagonized by viral regulatory proteins such as IE1 of human cytomegal

38 NA is regulated by a complex interplay among viral regulatory proteins, such as Tat, and host cellula

39 strate that the cellular factor YB-1 and the viral regulatory protein T-antigen interact both physica

40 g evidence of the oncogenic potential of the viral regulatory protein, T-antigen, and JCV's oncogenec

41 ich is responsible for the production of the viral regulatory protein, T-antigen.

42 tivation response element (TAR) RNA with the viral regulatory protein tat are of special interest due

43 rus (HIV) promoter depends on binding of the viral regulatory protein Tat to a cis-acting RNA regulat

44 pression depends upon the interaction of the viral regulatory protein Tat with the transactivation re

45 nal levels of protection by sequestering the viral regulatory proteins Tat and Rev, competing for enc

46 ikely that HTLV-1, through expression of the viral regulatory protein Tax(1), provides some initial a

47 HIV-1 Rev is an essential viral regulatory protein that facilitates the nuclear ex

48 of equine herpesvirus 1 (EHV-1) is an early, viral regulatory protein that independently trans-activa

49 ce of repression by the binding of the major viral regulatory protein to its high-affinity binding si

50 simplex virus infects permissive cells, the viral regulatory protein VP16 forms a specific complex w

51 The viral regulatory protein VP16 was readily detected in TG

52 us immediate-early gene transcription by the viral regulatory protein VP16.

53 nd functional interaction with Tat, a potent viral regulatory protein, Vpr synergistically enhances t

54 Expression of all three viral regulatory proteins was stimulated by dexamethason

55 osphorylation affects the activities of many viral regulatory proteins, we sought to determine whethe

56 ncreased the number of TG neurons expressing viral regulatory proteins, which enhanced virus shedding

57 The papillomavirus E2 protein is a critical viral regulatory protein with transcription, DNA replica